Price: 35.95

Today's Change: 0.24

Today's Percent Change: 0.67%

Today's Volume: 437248

Average Daily Volume: 369728

52 week low: 29.83

52 week high: 50.1

Market cap: 5960000000.0

EBITDA: 385370000.0

EBITDA / market_cap: 6.47%

Earnings per Share (EPS): 1.07

EPS / price: 2.98%

Dividend Yield: 0.87%

Dividend per share: 0.31

Book value: 11.64

Price to Book Ratio: 3.07

Price to Earnings (P/E) Ratio: 33.57

Price to Earnings Growth (PEG) Ratio: 0.0

Price to Sales (P/S) Ratio: 2.69

Short Ratio: 12.2

Exchange: "NYQ"

Short term: DOWN (Previous: UP)

Mid term: DOWN (Previous: UP)

Long term: DOWN (Previous: UP)

Support: 40.11

Resistance: 40.76

Pivot point: 40.51

SMA 10: 40.58

SMA 50: 40.82

SMA 100: 42.63

RSI 10: 45.31

RSI 50: 45.19

RSI 100: 46.39

EMA 10: 40.61

EMA 50: 40.90

EMA 100: 43.13


Based on 0 buy signals and 12 sell signals

Previous signal: strong sell




@ResearchPool: $RDY #Dr. Reddys Laboratories Ltd. ADS Morningstar | Dr. Reddys Fiscal Fourth-Quarter Results Broadly Met Our Expec…

@ResearchPool: $RDY #Dr. Reddys Laboratories Ltd. ADS Dr. Reddys Fiscal Fourth-Quarter Results Broadly Met Our Expectations: Dr. R…

@ProVesting: $ANIK $AGTC $RDY $AXGT: Dr. Reddy’s (RDY) Q4 Earnings Up Y/Y, Revenues Top Estimates:

@firsttomarkets: Dr. Reddy's Laboratories Ltd. Downgrade by Morgan Stanley (Ranked 32nd) to Equal-Weight $RDY #RDY

@AlertTrade: RT @Briefingcom: See the latest #broker #ratings changes $NOK $BURBY $LSI $NPTN $XEC $BIDU $DE $RDY $AAL $DAL $DB $…

@Briefingcom: See the latest #broker #ratings changes $NOK $BURBY $LSI $NPTN $XEC $BIDU $DE $RDY $AAL…

@Traderideas1: Follow his weekly list. Great info supplied here before Monday bell opens. Check him out…

@OpenOutcrier: Downgrades 5/20: $AAL $AGCO $AMTB $BMY $CLX $CRAY $DAL $DB $DE $EV $JHX $KEYS $MIK $PLD $PRA $RDY $SPN $ZAYO

@NewsToDesk: $RDY: Sell-siders cut Dr. Reddy’s after FQ4 report; shares down 5 …: